Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) EBT Margin (2016 - 2025)

Historic EBT Margin for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Q4 2016 value amounting to 4248.95%.

  • Rocket Pharmaceuticals' EBT Margin changed N/A to 4248.95% in Q4 2016 from the same period last year, while for Sep 2017 it was 1751.05%, marking a year-over-year change of. This contributed to the annual value of 1750.98% for FY2015, which is 8648500.0% up from last year.
  • Rocket Pharmaceuticals' EBT Margin amounted to 4248.95% in Q4 2016.
  • In the past 5 years, Rocket Pharmaceuticals' EBT Margin ranged from a high of 4917.22% in Q1 2016 and a low of 2119.62% during Q3 2016